Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
343.20    -1.00 (-0.29%)
Bid:
343.20
Ask:
343.80
Spread: 0.60 (0.175%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Senior Management Changes in New York and London

18 Mar 2011 16:41

18 March 2011

Tullett Prebon plc SENIOR MANAGEMENT CHANGES IN NEW YORK AND LONDON John Abularrage to be Chief Executive Officer the Americas Martin Lynch to be Chief Operating Officer the Americas

London and New Jersey, 18 March 2011: Tullett Prebon plc, ("Tullett Prebon") announces that John Abularrage has been appointed to become the next Chief Executive Officer ("CEO") the Americas, succeeding Marcus Bolton. Martin Lynch has also been appointed into the new created regional management role of Chief Operating Officer ("COO") the Americas.

Both John and Martin join the Company from Collins Stewart Inc. John has been CEO of that business since January 2009, having joined Collins Stewart in 2001 as a Director and becoming Head of Equities at that firm's London office in 2005. Before joining Collins Stewart John was an equity salesman at ABN Amro. He was educated at Georgetown University School of Business gaining a BSc in Business Administration. Martin has been Chief Financial Officer of Collins Stewart Inc since July 2008 having joined that firm as a Risk Manager in 2002 and becoming Finance Director of that firm's Capital Markets division in 2006. He was educated at the University of Southampton in the United Kingdom where he gained a BA in History and is a Chartered Certified Accountant.

The effective dates for these appointments are still to be confirmed.

Commenting on the appointment, Terry Smith Chief Executive Officer of Tullett Prebon said "Our Americas business remains one of our most valuable. In appointing John and Martin into these important roles we are increasing our regional management capability at an important time as we continue to rebuild our Americas business. As we reported in our Preliminary Results for 2010 earlier this month the Company has made excellent progress in re-establishing its presence in all of the major product areas in North America. Including a twenty-six strong credit team, who started with the business in January this year, our broker headcount on the affected desks is now largely back to previous levels; and the closure of our small satellite offices will allow management to focus on our two main offices in the Americas."

ENDS

Enquiries: Nigel Szembel +442072007722 or nszembel@tullettprebon.com

vendor
Date   Source Headline
29th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:25 pmRNSDirector/PDMR Shareholding
22nd May 202612:45 pmRNSHolding(s) in Company
13th May 20264:12 pmRNSResult of AGM
13th May 20264:12 pmRNSDirectorate change
13th May 20267:00 amRNSTrading Statement
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20269:00 amRNS2025 Annual Report and Notice of 2026 AGM
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20269:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:05 amRNSLaunch of sixth share buyback programme of £80m
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
5th Nov 20257:00 amRNSTrading Statement
2nd Oct 202510:15 amRNSDirector Declaration
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 202510:30 amRNSHolding(s) in Company
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:30 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.